Cargando…
Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
BACKGROUND: The dismal outcome of malignant peripheral nerve sheath tumor (MPNST) highlights the necessity of finding new therapeutic methods to benefit patients with this aggressive sarcoma. Our purpose was to investigate epidermal growth factor receptor (EGFR) as a potential therapeutic target in...
Autores principales: | Du, Xiaoling, Yang, Jilong, Ylipää, Antti, Zhu, Ze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878771/ https://www.ncbi.nlm.nih.gov/pubmed/24341609 http://dx.doi.org/10.1186/1756-8722-6-93 |
Ejemplares similares
-
Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
por: Du, Xiaoling, et al.
Publicado: (2022) -
Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor
por: Zhou, Wenya, et al.
Publicado: (2016) -
CT of malignant peripheral nerve sheath tumor
por: Lugo-Fagundo, Elias, et al.
Publicado: (2022) -
Malignant peripheral nerve sheath tumor: A rare malignancy
por: Sharma, Sheetal, et al.
Publicado: (2020) -
A–Z of malignant peripheral nerve sheath tumors
por: Kamran, S.C., et al.
Publicado: (2012)